Keyphrases
% Response
40%
3-cycle
20%
5-fluorouracil (5-FU)
20%
Carboplatin
20%
Cartilage Invasion
100%
Chemoradiation
60%
Chemoselection
100%
Cisplatin
20%
Concurrent Cisplatin
20%
Definitive Chemoradiation
20%
Disease-specific Survival
20%
Extralaryngeal Spread
20%
Histologic
40%
Invasion Spread
20%
Laryngeal Squamous Cell Carcinoma
100%
Larynx Preservation
40%
Neoadjuvant Chemotherapy
20%
One-cycle
40%
Organ Preservation
100%
Overall Survival
40%
Phase II Clinical Trial
20%
Primary Tumor
20%
Primary Tumor Response
20%
Sequential Phase
20%
Stage III-IV
20%
Total Laryngectomy
20%
Tracheostomy
20%
Medicine and Dentistry
Carboplatin
25%
Chemoradiotherapy
100%
Cisplatin
50%
Clinical Trial
25%
Disease Specific Survival
25%
Fluorouracil
25%
Laryngectomy
25%
Larynx
50%
Larynx Squamous Cell Carcinoma
100%
Neoadjuvant Chemotherapy
25%
Overall Survival
50%
Primary Tumor
50%
Squamous Cell Carcinoma
25%
Tracheostomy
25%